| 51 |
28775145 | Bypassing Drug Resistance Mechanisms of Prostate Cancer with Small Molecules that Target Androgen Receptor-Chromatin Interactions. | 2017 Oct |
1 |
| 52 |
26666359 | Estrone sulfate and dehydroepiandrosterone sulfate: Transactivation of the estrogen and androgen receptor. | 2016 Jan |
1 |
| 53 |
26813233 | Functional analysis of androgen receptor mutations that confer anti-androgen resistance identified in circulating cell-free DNA from prostate cancer patients. | 2016 Jan 26 |
2 |
| 54 |
26868122 | Androgen deprivation by adrenal suppression using low-dose hydrocortisone for the treatment of breast carcinoma with apocrine features: a case report illustrating this new paradigm. | 2016 Feb |
1 |
| 55 |
26998755 | Advantages and Limitations of Androgen Receptor-Based Methods for Detecting Anabolic Androgenic Steroid Abuse as Performance Enhancing Drugs. | 2016 |
1 |
| 56 |
27156843 | The neurobiology and addiction potential of anabolic androgenic steroids and the effects of growth hormone. | 2016 Sep |
1 |
| 57 |
27623747 | Refinement of the androgen response element based on ChIP-Seq in androgen-insensitive and androgen-responsive prostate cancer cell lines. | 2016 Sep 14 |
1 |
| 58 |
28096796 | Neuroendocrinology of a Male-Specific Pattern for Depression Linked to Alcohol Use Disorder and Suicidal Behavior. | 2016 |
1 |
| 59 |
24934352 | Novel Nor-Homo- and Spiro-Oxetan- Steroids Target the Human Androgen Receptor and Act as Antiandrogens. | 2015 |
2 |
| 60 |
25665553 | Targeting the androgen receptor in breast cancer. | 2015 Feb |
1 |
| 61 |
26008968 | Lemur Tyrosine Kinase 2, a novel target in prostate cancer therapy. | 2015 Jun 10 |
1 |
| 62 |
26036905 | Cell-based assays for screening androgen receptor ligands. | 2015 May |
1 |
| 63 |
26185616 | Cellular prostatic acid phosphatase (cPAcP) serves as a useful biomarker of histone deacetylase (HDAC) inhibitors in prostate cancer cell growth suppression. | 2015 |
1 |
| 64 |
23752196 | Androgen receptor functions in castration-resistant prostate cancer and mechanisms of resistance to new agents targeting the androgen axis. | 2014 May 29 |
2 |
| 65 |
24053777 | The transcriptional programme of the androgen receptor (AR) in prostate cancer. | 2014 Mar |
1 |
| 66 |
24465978 | Genetic variations in the androgen receptor are associated with steroid concentrations and anthropometrics but not with muscle mass in healthy young men. | 2014 |
3 |
| 67 |
24895212 | Negative regulation of the androgen receptor gene through a primate-specific androgen response element present in the 5' UTR. | 2014 Oct |
1 |
| 68 |
24922532 | Ubiquitin Specific Protease 26 (USP26) expression analysis in human testicular and extragonadal tissues indicates diverse action of USP26 in cell differentiation and tumorigenesis. | 2014 |
2 |
| 69 |
24936953 | Targeting the androgen receptor with steroid conjugates. | 2014 Oct 23 |
2 |
| 70 |
24948873 | Beyond T and DHT - novel steroid derivatives capable of wild type androgen receptor activation. | 2014 |
4 |
| 71 |
25034089 | A novel mutation (c.2735_2736delTC) in the androgen receptor gene in 46,XY females with complete androgen insensitivity syndrome in an Egyptian family. | 2014 |
4 |
| 72 |
25356728 | Prostate cancer characteristics associated with response to pre-receptor targeting of the androgen axis. | 2014 |
3 |
| 73 |
27683456 | Mechanisms of Androgen-Independent Prostate Cancer. | 2014 Apr |
1 |
| 74 |
23169992 | SIRT1 represses estrogen-signaling, ligand-independent ERα-mediated transcription, and cell proliferation in estrogen-responsive breast cells. | 2013 Mar |
1 |
| 75 |
23260236 | Docking and CoMSIA studies on steroids and non-steroidal chemicals as androgen receptor ligands. | 2013 Mar |
2 |
| 76 |
23675320 | Supraphysiological doses of performance enhancing anabolic-androgenic steroids exert direct toxic effects on neuron-like cells. | 2013 |
3 |
| 77 |
23793763 | Molecular biology of castration-resistant prostate cancer: basis for the novel therapeutic targets. | 2013 Jun |
4 |
| 78 |
23859952 | Androgen receptors in hormone-dependent and castration-resistant prostate cancer. | 2013 Dec |
1 |
| 79 |
24279585 | Estrogen and androgen receptor expression in surface epithelium and inclusion cyst in the ovary of premenopausal and postmenopausal women. | 2013 Nov 27 |
2 |
| 80 |
24299210 | Nur77 inhibits androgen-induced bladder cancer growth. | 2013 Dec |
1 |
| 81 |
25866551 | Proline-Directed Androgen Receptor Phosphorylation. | 2013 Oct |
2 |
| 82 |
21822504 | Intrinsic disorder in the androgen receptor: identification, characterisation and drugability. | 2012 Jan |
2 |
| 83 |
22402316 | Androgen action in the prostate gland. | 2012 Mar |
2 |
| 84 |
22449547 | Steroid derivatives as pure antagonists of the androgen receptor. | 2012 Oct |
2 |
| 85 |
22477185 | Emerging roles of the ubiquitin-proteasome system in the steroid receptor signaling. | 2012 Mar |
2 |
| 86 |
22505344 | Effects of a human compact anti-ErbB2 antibody on prostate cancer. | 2012 Jul |
1 |
| 87 |
22549187 | [Genome-wide approaches for clarification of androgen receptor function]. | 2012 May |
2 |
| 88 |
22577344 | Cross-regulation between FOXA1 and ErbB2 signaling in estrogen receptor-negative breast cancer. | 2012 Apr |
1 |
| 89 |
23344235 | Antisense 2'-Deoxy, 2'-Fluroarabino Nucleic Acids (2'F-ANAs) Oligonucleotides: In Vitro Gymnotic Silencers of Gene Expression Whose Potency Is Enhanced by Fatty Acids. | 2012 Sep 18 |
1 |
| 90 |
21193555 | Cytoplasmic accumulation of incompletely glycosylated SHBG enhances androgen action in proximal tubule epithelial cells. | 2011 Feb |
1 |
| 91 |
21239012 | Novel therapeutic strategies for castration resistant prostate cancer: inhibition of persistent androgen production and androgen receptor mediated signaling. | 2011 Mar |
1 |
| 92 |
21327417 | Androgen receptor CAG repeat size is associated with stress fracture risk: a pilot study. | 2011 Oct |
1 |
| 93 |
21365123 | Steroidogenic enzymes and stem cell markers are upregulated during androgen deprivation in prostate cancer. | 2011 |
2 |
| 94 |
21372378 | (17α,20E)-17,20-[(1-methoxyethylidene)bis(oxy)]-3-oxo-19-norpregna-4,20-diene-21-carboxylic acid methyl ester (YK11) is a partial agonist of the androgen receptor. | 2011 |
2 |
| 95 |
21397203 | Prostate diseases--role of sex steroids and their inhibitors. | 2011 Apr |
1 |
| 96 |
21457548 | Synergy between inhibitors of androgen receptor and MEK has therapeutic implications in estrogen receptor-negative breast cancer. | 2011 Apr 1 |
2 |
| 97 |
21532617 | Differential regulation of PTEN expression by androgen receptor in prostate and breast cancers. | 2011 Oct 20 |
1 |
| 98 |
21796517 | Molecular mechanisms of androgen action--a historical perspective. | 2011 |
1 |
| 99 |
21796524 | Analysis of interdomain interactions of the androgen receptor. | 2011 |
1 |
| 100 |
21828060 | Selective changes of retroelement expression in human prostate cancer. | 2011 Oct |
1 |